SOLVENTUM CORP (SOLV)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for SOLV
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| SOLV | Former SVP, Strategy and Business Development and Licensing, Covidien Inc.; Director | 65 | ["Former SVP, Strategy and Business Development and Licensing, Covidien Inc.", "Over 30 years of experience in strategic leadership roles and member of multiple boards at healthcare and medical device companies", "Deep knowledge through executive and board experience of financial valuation and portfolio optimization", "Service on the boards and in senior strategy roles at global healthcare and medical device companies", "Extensive and thorough experience in guiding companies undergoing significant transitions, including M&A, as well as portfolio management and spin-offs", "Considerable experience overseeing acquisition and portfolio management of science and research companies", "Strategic responsibility for large multinational companies operating in regulated industries; Roles in product development and licensing and distribution", "Oversight in multiple roles of revenue growth and margin enhancement for large global companies", "Significant experience with mergers and acquisitions as well as divestitures for multiple public and private companies with oversight over strategic risk", "Leadership of large teams particularly in performance and advancement; Roles on public company boards with oversight over human capital management"] | ["GC", "STQC", "Governance", "Science, Technology and Quality"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| BAX | Former Senior Vice President of Strategy and Business Development, Covidien plc; Independent Director | 65 | ["Extensive experience in business development and strategy in the healthcare industry, including significant mergers & acquisitions and integration experience", "Expertise in portfolio management and resource allocation decision making", "Former Senior Vice President of Strategy and Business Development at Covidien plc", "Senior Advisor for the Healthcare Investment Banking Practice at Perella Weinberg Partners L.P.", "Significant experience in financial valuation, resource allocation and portfolio optimization", "Extensive experience in research and development operations", "Deep expertise in mergers and acquisitions, divestitures, strategic transitions and identifying new market opportunities", "International executive experience in global healthcare and medical device companies", "Healthcare Marketing / Delivery", "Quality, Regulatory and Compliance", "Other Sector Leadership"] | ["Compensation and Human Capital", "Quality and Regulatory Compliance", "Quality and Regulatory Compliance Committee"] | 2026 |
Biography sourced from the proxy statement filing.
Professional experience Perella Weinberg Partners Senior Advisor, Healthcare Investment Banking (2016 2019) McKinsey & Company Senior Advisor, Strategy and Corporation Finance (2015 2018) Covidien plc Senior Vice President of Strategy and Business Development (2006 2015) Skills and experience supporting nomination Amy A. Wendell 65 Director since 2024 Board committees Governance; Science, Technology and Quality Current public company directorships AxoGen, Inc. (2016 - Present) Baxter International, Inc. (2019 - Present) Hologic, Inc. (2016 - Present) Ms. Wendell s extensive business development and strategy experience in the healthcare industry provides valuable insights for the Board. In particular, Ms. Wendell has deep expertise in all areas of mergers and acquisitions, portfolio management, resource allocation, and identification of new market opportunities. Ms. Wendell holds a Bachelor of Science in Mechanical Engineering from Lawrence Technological University and a Master of Science degree in Biomedical Engineering from the University of Illinois. Healthcare Industry Over 30 years of experience in strategic leadership roles and member of multiple boards at healthcare and medical device companies Financial Acumen & Experience Deep knowledge through executive and board experience of financial valuation and portfolio optimization International & Global Operations Service on the boards and in senior strategy roles at global healthcare and medical device companies Strategy & M&A Extensive and thorough experience in guiding companies undergoing significant transitions, including M&A, as well as portfolio management and spin-offs Science, Technology, Research & Innovation Considerable experience overseeing acquisition and portfolio management of science and research companies Quality, Regulatory & Compliance Strategic responsibility for large multinational companies operating in regulated industries; Roles in product development and licensing and distribution Corporate Sales, Marketing & Brand Management Oversight in multiple roles of revenue growth and margin enhancement for large global companies Risk Management Significant experience with mergers and acquisitions as well as divestitures for multiple public and private companies with oversight over strategic risk Human Capital Management Leadership of large teams particularly in performance and advancement; Roles on public company boards with oversight over human capital management